Signs of a safety problem have Surface Oncology cutting back clinical trial plans for its lead drug only eight months after the company completed a $108 million IPO to finance clinical tests of the drug.

Austin—Waldo Photos, a startup with facial recognition software that helps its users find photos of themselves and family members, has raised $4 million in a new round of financing led by Lewis & Clark Ventures.

When it comes to getting a drug into a cell, size matters. Small molecules can easily pass through the cellular membrane in a way that larger therapeutic proteins can’t, which makes it difficult to develop a biological drug that can reach... Read more »

Seattle biotech company Kineta continues to expand its roster of drug development partners, announcing on Monday it has entered into a collaboration and licensing agreement with Pfizer to develop therapies that use the body’s disease-fighting capabilities to attack cancerous tumors.

Omid Farokhzad has, as he says, “been around the block a few times” in biotech. The cancer nanomedicine researcher has cofounded a handful of companies that have tried to develop nanotech-based and other drugs for cancer and other diseases. But their... Read more »

DataCloud, a developer of sensors and software to help guide mine operators’ decision-making around drilling and blasting, has raised $4 million in new financing to support the Seattle-based startup’s continued growth.

The company’s system combines cloud-based software with connected sensors... Read more »

Cogito, the A.I. startup that wrings emotional intelligence cues out of the human voice, is training its focus on call centers and splitting off its behavioral health unit into a new enterprise called CompanionMX.

The University of Michigan’s Desai Accelerator, an incubator open to early-stage tech startups regardless of their connection to the school, hit a major milestone this year: It invested its millionth dollar after funding the six companies in its 2018 cohort.... Read more »